Chris Bosh's Blood Clot Warning to Wembanyama Is a Fantasy Wake-Up Call
Bosh says he 'almost dropped dead' from a January pulmonary embolism. His advice to Wemby matters — and so does what it means for your 2026-27 draft.
Elite production returned in 64 games; any clot-related discount is a gift.
- Wemby: 53.4 FPTS/G last season (2025-26), our #3 overall
- Played 64 games after clot cut short 2024-25
- Bosh: two clots, career over at 31
- Bosh hospitalized a week in January 2026
- Wemby +14.1 FPTS over last-5 average (2025-26)
Chris Bosh went public this week with a scare that puts every blood-clot conversation in the NBA back on the table. The 42-year-old Hall of Famer told an interview published Monday that he suffered another pulmonary embolism in January, spent a week in the hospital, and, in his words, almost dropped dead before coming back. It was the same condition — clots twice, in fact — that ended his 11-time All-Star career at just 31.
Bosh directed a piece of that message straight at Victor Wembanyama, whose 2024-25 season was cut short by his own blood clot. Bosh's advice was blunt: take the medicine, stay on the regimen, because it only takes one more episode. He knows firsthand — the second clot cost him basketball for good.
Here's the part fantasy managers need to hear next to that sobering warning: Wembanyama came all the way back. He played 64 games in 2025-26, dragged the Spurs to the Western Conference championship and a Finals berth, finished as an MVP finalist, and won Defensive Player of the Year in year three. This wasn't a cautious re-entry. It was a superstar leap.
What the Numbers Say
Wemby posted 25 points, 11.5 rebounds and 3.1 assists per game last season (2025-26), good for 53.4 fantasy points per contest in our scoring. That's the #3 overall player on our board and #1 at his position. His form only sharpened late — over his final five games he averaged 14.1 fantasy points above his season mark. You don't fake that kind of finish coming off a clot.
The Bosh comparison is emotional, but the medical reality is different in one important way: Wemby's team managed him and he still produced at an elite clip across a near-full slate. Bosh's clots forced retirement; Wemby's cost him a season and then he returned as one of the two or three most valuable assets in fantasy basketball.
The Fantasy Verdict
Treat this as a monitoring situation, not a red flag to fade. If a nervous leaguemate is willing to knock Wembanyama down a peg over clot anxiety, that's a buy-low window on a top-three player. Draft him with confidence in the early first round of 2026-27, keep an eye on any load-management news out of San Antonio, and don't let one legend's cautionary tale talk you out of the best young building block in the sport.
